Hema-Care
Hema-Care® is used for the treatment of anaemias.
It contains the common substances used in the
prevention and treatment of anaemic conditions.
Hema-Care® is used for the treatment of anaemias.
It contains the common substances used in the
prevention and treatment of anaemic conditions.
Indicated for the treatment and prophylaxis of common
anaemias, including:
- iron-deficiency anaemias.
- megaloblastic anaemias of pregnancy.
- pellagra.
One capsule daily with or after meal.
Overdosage:-
- Symptoms of overdosage can be any of those described
under "Side-effects and Special Precautions" below.
- If any symptoms of intolerance occur, the drug should
be temporarily or permanently discontinued.
- In acute poisoning the desferrioxamine should be
administered under the direction of a physician but
preferably should not be administered during the
pregnancy. Alternatively, and preferably in the
treatment during pregnancy and lactation, empty the
stomach by inducing emesis using ( 1 - 5% ) solution
of sodium bicarbonate lavage.
- Any small dose(as one gram) of iron is very toxic in
children.
Each soft gelatin capsule contains:
- Ferrous fumarate 300 mg
- Pyridoxine HCL(vitamine B6) 1.2 mg
- Folic acid 1.0 mg
- Cyanocobalamin (vitamine B12) 7.5 mcg
- Zinc sulphate monohydrate 66 mg
- Hypersensitivity to any of the ingredients.
- Symptoms of iron intolerance.
- Iron salts and tetracycline absorption is diminished if taken
concomitantly by mouth.
- Iron salts should be administered 3 hours before or 2 hours
after the tetracycline administration.
- Concomitant ingestion of antiacids and tea will also
decrease the absorption of iron salts.
- Iron salts may reduce the effects of penicillamine.
- Quinolone anti-infective agent absorption is diminished if
taken concomitantly by mouth with iron salts. Oral
preparations should not be administered within two hours
of quinolone agents.
Hema-Care® can be used during pregnancy and lactation,
(prescribed by physician or pharmacist).
- Excessive doses of iron preparations may lead to toxicity
in children.
- Adverse effects of iron administered in therapeutic doses
may include gastro-intestinal discomfort, diarrhea,
vomiting, constipation.
- Sideeffects may be reduced by taking the medication with
or immediately after food. As a result of iron therapy stools
may become darkened or black in colour.
- Circulatory failure may occur if the diarrhea and
haemorrhage are severe.
- Iron salts should not be given to patients receiving
repeated blood transfusions or to patients with
anaemias not produced by iron deficiency unless iron
deficiency is also present.
- Care should be taken when given to patients with
iron-storage or iron-absorption diseases,
haemoglobinopathies, or existing gastro-intestinal disease.
- Blister of 15 capsules, pack of 2 blisters.
- Store at temperature below 30°C.
- Protect from humidity and light.